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Methadone maintenance treatment,
criminality and overdose-related deaths
An ecological study, 1983–1999
GÉRARD NIVEAU, ANNE-LAURE ROUGEMONT, ROMANO LA HARPE *
Background: Methadone maintenance treatments (MMTs) are the commonest substitution treatments offered to
opiate addiction in Switzerland, in order to reduce criminal behaviour, infectious disease transmission and overdose
death. Method: To investigate the relationship between the increase in the number of methadone maintenance
treatments, criminal activity of addicts and overdose-related deaths, an ecological study was undertaken in the Canton
of Geneva, from 1983 to 1999. Results: The regular and extensive increase in the number of MMTs is not significantly
associated, during the 1983–1999 period, with a fall either in drug addict incarcerations or in overdose-related
deaths. However, a slight decrease is observed in the number of imprisoned opiate addicts since 1994, and a marked
decrease is seen in overdose deaths from 1997 on. An important and stable number of these deaths is due to
methadone itself. Conclusion: Public health objectives to diminish delinquency and overdose deaths cannot solely
be fulfilled by extensive use of MMTs. A positive result could appear when access to MMT is highly favoured. This
hypothesis must be proved correct by observational studies conducted on a general population.
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The three main aims of public health policies based on
large-scale use of methadone maintenance treatments
(MMTs) were a decrease in delinquency, prevention of
overdoses and a decrease in the spread of infectious
diseases by the intravenous route, notably hepatitis
and HIV.1 These health policies were supported by
encouraging results from randomized controlled trials and
observational studies.2 These studies concerned selected
populations, which introduces a risk of bias in spite of a
precise methodology.3 When MMTs were widely pre-
scribed to the general population, patients did not always
undergo equal selection and the results of the MMTs were
not always those that had been expected.4
A study has been made considering a non-selected general
population, in order to appreciate the global results
obtained after many years of MMT use in the care and
treatment of drug addicts. However, no reliable data on
the evolution of the intravenous spread of infectious
diseases could be obtained. For this reason, the study
considers the impact of MMTs on delinquency and over-
dose deaths only.
METHODS
The study is designed as an ecological study and analyses
the impact of a therapeutic factor (use of MMTs in the
medical care of drug addicts) on a delinquency indicator
and on a health indicator (mortality by overdose). The
study takes into account the population residing in the
canton of Geneva, Switzerland, over a period of 17 years
(1983–1999). The number of opiate addicts residing in
the canton each year is not known. As a factorial variable,
the annual prevalence rate of maintenance treatments
per 1000 Geneva residents has been used. The data
relating to the residing population in the canton and the
number of MMTs was supplied by the Cantonal Office of
Statistics.
The variable used to describe the evolution of criminality
amongst drug addicts is the prevalence of imprisoned drug
addicts per 1000 Geneva residents. Notably, this variable
takes into account only delinquency leading to incarcera-
tion; false accusations are excluded, since imprisonment
of innocents is extremely rare. The prisoners needing an
opiate withdrawal treatment or a maintenance treatment
have been considered as drug addicts. Data on the number
of drug addicts cared for in prison has been provided by
the medical staff of the prison system of the canton of
Geneva.
The variable used to describe the evolution of overdose
deaths due to opiates was the mortality rate per 100,000
Geneva residents.
In the canton of Geneva, information on causes of death
is reliable, since by judicial decision any apparently un-
natural death is examined by a forensic examiner at the
Geneva Institute of Forensic Medicine. All homicidal or
accidental deaths, the latter including overdoses, lead to
a necropsy and to a blood analysis, in search of toxic
substances. In the present study, the annual numbers of
overdoses were provided by the Geneva Institute of
Forensic Medicine, and not by police records.
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The identification of the substance directly responsible
for death depends on the results of the blood analysis. If
a given drug, heroin or methadone, is found at potentially
lethal doses and if autopsy findings corroborate the in-
toxication hypothesis, then one or the other substance is
retained as causative, even though other licit or illicit
drugs may be present at low doses. On the contrary, if the
analysis reveals high doses of different substances, the
cause of death will then be attributed to a mixed
intoxication. Deaths clearly related to heroin or to
methadone intoxications have been considered for the
entire 1983–1999 period; deaths due to a mixed in-
toxication, including heroin or methadone, were con-
sidered from 1988 on.
Spearman’s row correlation coefficient was used to test
the significance of the association between the factor and
the indicators of mortality and delinquency.
RESULTS
Table 1 shows that the prevalence rate of MMTs has
regularly increased, sevenfold between 1983 and 1999.
Importantly, the therapeutic factor has been modified
significantly during the 17 years of the study.
In table 2, it is observed that the prevalence rate of
imprisoned drug addicts continued to rise until 1993, then
decreased, before becoming stable from 1996 on. The
number of prisoners in need of a withdrawal treatment
increased from the beginning of the study period until
1992–1993. From then on, prisoners have been able to
continue in prison a MMT that had been started before
incarceration. This has decreased the number of
withdrawal treatments and increased the number of
maintenance treatments within prisons.
Spearman’s row correlation coefficient is r=0.73, (df=15),
p<0.01. The increase in MMTs is thereby significantly
associated with an increase instead of a decrease in the
number of imprisoned drug abusers.
Table 3 shows that the number of overdoses within the
Geneva population has varied between 4 and 9 per
100,000 residents, between 1983 and 1999. The rate
abruptly fell to 3 per 100,000 from 1997 on. Since 1990,
an increase in the number of methadone-related deaths
is observed, with stabilization at about 1 to 1.5 cases per
100,000 residents.
Spearman’s row correlation coefficient is r= –0.09,
(df=15), NS. It can be concluded that the increase in
MMTs is not thereby associated with any significant
modification, in one direction or another, of the number
of overdose-related deaths. The recent decrease in these
deaths is not enough to modify Spearman’s coefficient.
Table 4 shows that deaths due to a mixture of substances,
including methadone or heroin, are infrequent, even
though numbers have tended to rise during recent years.
Because of the low number of cases and years examined,
no statistical analysis has been conducted.
DISCUSSION
Analyses suggest that the extensive use of MMTs
within health policies regarding drug addicts cannot be
associated with a decrease in the incarceration of these
Table 1 Number and rate of methadone maintenance treatments (MMTs) in the canton of Geneva
Year
1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Residents in 
the canton 
(thousands) 365 369 371 375 377 379 378 383 385 387 391 396 399 400 401 403 408
Total number 
of MMTs 200 225 300 340 360 393 389 637 788 808 962 1141 1205 1342 1398 1464 1531
Prevalence rate
of MMTs (per
1000 residents) 0.55 0.61 0.81 0.91 0.95 1.04 1.03 1.66 2.05 2.09 2.46 2.88 3.02 3.36 3.49 3.63 3.75
Table 2 Number and rate of incarcerated opiate addicts in the canton of Geneva
Year




withdrawal 187 218 212 183 235 210 240 260 280 328 326 282 212 191 157 147 147
Inmates treated
with MMT 0 0 0 0 0 0 0 0 0 30 72 84 105 98 137 150 123





residents) 0.51 0.59 0.57 0.49 0.62 0.55 0.63 0.68 0.73 0.93 1.02 0.92 0.79 0.72 0.73 0.74 0.66
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patients nor with a fall in the number of overdose-related
deaths.
Until 1993, it is very clear that MMTs had no effect on
the imprisonment of drug addicts. From 1993 until 1999,
the number of incarcerations first diminished and then
stabilized, but in magnitude such that the direction of the
correlation coefficient is not altered. This fall could be
explained by a decision taken in 1993 by the justice
authorities not to imprison drug addicts solely because of
unpaid bills. Other possible hypotheses could be a delayed
effect of the MMT or a fall in the number of heroine
addicts. However, in 1998 and in 1999, it is observed that
the numbers of imprisoned drug addicts who are or are not
undergoing MMT are similar. The small impact of MMT
on delinquency has already been mentioned in different
observational studies conducted in the United States,5
Holland,6 Canada7 and the UK.8 Different explanations
for this lack of efficiency have been discussed: a widening
of the indication to the treatment, a lack of rigour in
conduction of the treatment, the existence of de-
linquency prior to the drug addiction, and the abuse of
heroine or of other drugs during the MMT.9
The lack of relationship between the increase in the
number of MMTs and mortality due to overdose is clearly
seen throughout the whole of the studied period. These
results are surprising since cohort studies usually show that
the mortality of patients undergoing a MMT programme
is very low compared to that of patients who have not
entered these programmes.10–12
One hypothesis could be that, in the absence of the great
increase in the number of MMTs, the rate of heroin
addicts dying of overdose would have been much higher;
this kind of element doesn’t appear in an ecological study.
The fact that a large number of the overdoses is due to
methadone itself is a disturbing result. Numerous studies
have shown the dangers of large-scale methadone pre-
scription.13–16 A recent study conducted by Hall et al.17
concerning the UK and Australia shows that, as in this
present study, overdoses due to opiates constantly in-
creased in these two countries during the 1980s and
1990s. This was observed despite the MMT programmes.
It was also observed that when MMT programmes
increase considerably, this is accompanied by a fall in
heroine-related overdoses and by an increase in metha-
done-related overdoses.17 During the last three years of
the Geneva study, overdoses decreased, but half of them
were due to methadone. The fall in mortality observed
during these three years could be explained by different
hypotheses, notably a decrease in the use of opiates due
to the emergence of new drugs on the market and the
beginning of treatment programmes using medically con-
trolled prescription of heroine.
It is important to recognize the limitations of ecological
studies. The results are based on aggregate data and are
subject to bias by confounding factors, whose effects are
difficult to assess. One of these confounding factors could
be, as mentioned above, changes due to new political
decisions taken by the justice and police authorities.
Changes concerning incarceration decisions as well as
those concerning examination requirements for a non-
natural death have been rare in Geneva between 1983
and 1999. Variations in the numbers of drug addicts could
also be another confounding factor, since we can
postulate that they must have increased in Geneva as in
the majority of industrialized large cities. This increase
is nevertheless lower than the increase in MMTs,
which have gone up sevenfold during the period of the
study.
In other respects, the increasing simultaneous use of
multiple psychotropic substances can lead to a mis-
evaluation of the number of deaths due to opiates. This
current study shows, during the 1996–1999 period, a
Table 3 Number and rate of lethal opiate overdoses in the canton of Geneva
Year
1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Number of 
heroin-related
overdoses 14 13 12 14 14 32 27 22 18 24 16 28 21 20 8 7 9
Number of
methadone- 
related overdoses 3 2 2 2 4 1 0 5 2 5 7 6 3 6 5 5 4




residents) 4.66 4.07 3.77 4.27 4.77 8.71 7.14 7.05 5.19 7.49 5.88 8.59 6.02 6.5 3.24 2.98 3.19
Table 4 Number of overdoses due to different associated substances, including heroin or methadone, in the canton of Geneva
Year
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Number of overdoses due to
mixed intoxication 0 2 0 1 1 4 2 2 4 3 4 4
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diminution in deaths related to heroin, whereas the
number of overdoses due to methadone or to different
associated substances increased. If we consider that
abusers who die of a mixed overdose belong to a group
similar to the heroin-related death group, then this could
confirm the low impact of MMTs. However, one can also
consider the fact that individuals abusing multiple
psychotropic drugs could form a particular group of
abusers that are not involved in MMTs.
Despite these limitations, the ecological design was the
most appropriate to evaluate the real impact in the
general population of the MMTs on delinquency and
mortality due to overdose. These results have an
important consequence for research in this field. The fact
that a large population of prisoners now benefit from a
MMT should be analysed in a comparative study with
prisoners without MMT and patients undergoing a MMT
that are not incarcerated, so as to understand the reasons
for the failure of delinquency prevention.
The improvement in delinquency and mortality indices
of the last three years will have to be confirmed by a future
study.
On clinical grounds, this study shows that the extensive
use of MMTs is not an easy solution to every problem
related to heroine addiction. However, these clinical
results must be considered cautiously, since the third
expected effect of MMTs (a decrease in intravenous
spread of infectious diseases) has not been analysed. A
longitudinal study conducted by Broers et al. in Geneva
has shown a clear decrease in HIV incidence rates
amongst drug addicts undergoing a MMT.18
MMTs are a therapeutic agent in the medical care of
heroine addicts, but no major prevention of delinquency
or overdose deaths can be expected from these treatments.
Moreover, constant changes to the drugs scene require
adjustments of the therapeutic and preventive means.
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